| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |